Iterum Therapeutics Announces $52 Million Private Placement with New and Existing Investors DUBLIN, Ireland and CHICAGO, Jan. 17, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on...
Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2020 Milestones – Ripretinib Marketing Applications Submitted to Health Canada and Australia’s Therapeutic Goods Administration for Patients with Advanced GIST via the U.S. FDA’s Project...
Recent Comments